# Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

> **NCT00206492** · PHASE2 · TERMINATED · sponsor: **Baylor Breast Care Center** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Iressa
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00206492
- **Lead sponsor:** Baylor Breast Care Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** halted by the PI only 3 of 45 subjects were accrued.
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206492, "Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00206492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*